Arie Belldegrun insider trades: Lb Pharmaceuticals (LBRX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Arie reports to the SEC
and 6 more companies
Open-market buys and sales
16 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 12, 2025 | LBRX | ↑ Buy | 332,566 | $15.00 | $5.0M | By Vida Ventures III, L.P. | Sep 16, 2025 (4d) |
| Sep 12, 2025 | LBRX | ↑ Buy | 767 | $15.00 | $12K | By Vida Ventures III-A, L.P. | Sep 16, 2025 (4d) |
| May 16, 2024 | ALLO | ↑ Buy | 1,724,137 | $2.90 | $5.0M | Indirect | May 20, 2024 (4d) |
| Jan 12, 2022 | ALLO | ↑ Buy | 155,039 | $12.60 | $2.0M | Indirect | Jan 14, 2022 (2d) |
| Jun 4, 2020 | ALLO | ↑ Buy | 146,382 | $47.00 | $6.9M | Indirect | Jun 4, 2020 (0d) |
| Oct 15, 2018 | ALLO | ↑ Buy | 35,000 | $18.00 | $630K | Direct | Oct 17, 2018 (2d) |
| Sep 25, 2017 | KITE | ↓ Sell | 26,347 | $179.66 | $4.7M | Direct | Sep 27, 2017 (2d) |
| May 9, 2017 | KITE | ↑ Buy | 17,000 | $68.57 | $1.2M | Direct | May 9, 2017 (0d) |
| Dec 20, 2016 | KITE | ↓ Sell | 3,493 | $50.86 | $178K | Direct | Dec 22, 2016 (2d) |
| Jan 12, 2016 | ARNI | ↑ Buy | 1,448,062 | $0.35 | $507K | Arie S. Belldegrun, M.D. Inc. Profit Sha | Jan 14, 2016 (2d) |
| Jan 12, 2016 | ARNI | ↑ Buy | 714,285 | $0.35 | $250K | Leumi Overseas Trust Corp. Ltd. as TTEE | Jan 14, 2016 (2d) |
| Feb 21, 2008 | CGRB | ↑ Buy | 5,000 | $27.00 | $135K | Direct | Mar 3, 2008 (11d) |
| Dec 18, 2007 | CGRB | ↑ Buy | 15,000 | $30.50 | $458K | Direct | Dec 20, 2007 (2d) |
| Jun 18, 2007 | CGRB | ↑ Buy | 3,700 | $23.90 | $88K | Direct | Jun 19, 2007 (1d) |
| May 8, 2007 | CGRB | ↑ Buy | 7,100 | $21.10 | $150K | Direct | May 10, 2007 (2d) |
| Feb 27, 2007 | CGRB | ↑ Buy | 15,000 | $18.33 | $275K | Direct | Mar 9, 2007 (10d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Arie Belldegrun's insider trades
Arie Belldegrun is an insider at Lb Pharmaceuticals (LBRX). Since Feb 27, 2007, Arie has reported 14 open-market purchases worth $22.5M and 2 sales worth $4.9M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (46 filings), other transactions (14 filings), conversions (6 filings), shares returned to the company (6 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every LBRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.